Technology in Cancer Research & Treatment (Oct 2024)
Letter to the Editor: EGFR-TKIs Combined with Allogeneic CD8+ NKT Cell Immunotherapy to Treat Patients with Advanced EGFR-Mutated Lung Cancer
Abstract
No abstracts available.
Technology in Cancer Research & Treatment (Oct 2024)